미국의 유방 보형물 시장 규모, 점유율, 동향 분석 리포트 : 제품 유형별, 재료 유형별, 용도/적응증별, 유통 채널별, 부문별 예측(2025-2033년)

U.S. Breast Prosthetic Market Summary

The U.S. breast prosthetic market size was estimated at USD 121.75 million in 2024, and is projected to reach USD 241.11 million by 2033, growing at a CAGR of 7.94% from 2025 to 2033. This growth is attributed to the rising incidence of breast cancer, increasing rates of mastectomy procedures, advancements in prosthetic materials and design, growing awareness regarding post-mastectomy options, and improved insurance coverage and reimbursement policies.

According to the Breast Cancer Organization, in 2025, approximately 316,950 women will be diagnosed with invasive breast cancer, with 59,080 new cases of ductal carcinoma in situ, which is non-invasive. About 16% of women with breast cancer are younger than 50 years of age.

Increasing investment in breast cancer research, awareness campaigns, and healthcare infrastructure is a key driver of the breast prosthetic market. Government bodies, non-profit organizations, and private companies are channeling substantial funds into early detection programs, public education, and improved treatment options. These investments have led to earlier diagnoses and higher survival rates, which in turn raise the demand for post-mastectomy solutions such as breast prostheses. Furthermore, funding has enabled the development of advanced, more comfortable, and aesthetically realistic prosthetic products, enhancing patient satisfaction and adoption. Investments also support training programs for healthcare providers, ensuring better post-surgical counseling and expanding access to prosthetic care. Collectively, these initiatives contribute to a more supportive ecosystem for breast cancer survivors, thereby boosting the market growth in the U.S.

U.S. Breast Prosthetic Market Report Segmentation

This report forecasts revenue growth at regional and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 - 2033. For this study, Grand View Research has segmented the U.S. breast prosthetic market report based on product type, material type, application/indication, distribution channel.

• Product Type Outlook (Revenue, USD Million, 2021 - 2033)
• Full Breast Prosthesis
• Partial Breast Prosthesis (Shapers/Shells)
• Specialty/Functional Prosthesis
• Material Type Outlook (Revenue, USD Million, 2021 - 2033)
• Silicone breast forms
  • Standard Silicone
  • Lightweight
• Foam and fabric breast forms/Non-silicone
• Others (custom polymer blends, 3D printed)
• Application/Indication Outlook (Revenue, USD Million, 2021 - 2033)
• Post-Mastectomy Care
• Lumpectomy/Partial Mastectomy
• Breast Augmentation (Non-Surgical)
• Congenital Asymmetry
• Others
• Distribution Channel Outlook (Revenue, USD Million, 2021 - 2033)
• Online Retailers/E-commerce Platforms
• Retail Pharmacies & Medical Supply Stores
• Specialty Stores & Lingerie Boutiques
• Direct Sales (Manufacturer to Provider/Consumer)
• Hospital & Clinic Sales (Procurement)

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Product Type
  • 1.2.2. Material Type
  • 1.2.3. Application/Indication
  • 1.2.4. Distribution Channel
• 1.3. Estimates and Forecast Timeline
• 1.4. Research Methodology
• 1.5. Information Procurement
  • 1.5.1. Purchased Database
  • 1.5.2. GVR's Internal Database
  • 1.5.3. Secondary Sources
  • 1.5.4. Primary Research
• 1.6. Information Analysis
  • 1.6.1. Data Analysis Models
• 1.7. Market Formulation & Data Visualization
• 1.8. Model Details
  • 1.8.1. Commodity Flow Analysis
• 1.9. List of Secondary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Competitive Insights

Chapter 3. U.S. Breast Prosthetic Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Ancillary Market Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Rising incidence of breast cancer
    • 3.2.1.2. Strong investments in breast cancer research
    • 3.2.1.3. Supportive insurance and reimbursement policies
    • 3.2.1.4. Growing preference for non-surgical reconstruction
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. High cost of premium products
    • 3.2.2.2. Discomfort or inconvenience with long-term use
  • 3.2.3. Market Opportunities Analysis
    • 3.2.3.1. Expansion of Direct-to-Consumer (DTC) and E-commerce channels
    • 3.2.3.2. Increasing focus on inclusive and aesthetic designs
  • 3.2.4. Market Challenge Analysis
    • 3.2.4.1. Rising competition among industry participants
• 3.3. U.S. Breast Prosthetic Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Bargaining power of suppliers
    • 3.3.1.2. Bargaining power of buyers
    • 3.3.1.3. Threat of substitutes
    • 3.3.1.4. Threat of new entrants
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political & Legal Landscape
    • 3.3.2.2. Economic and Social Landscape
    • 3.3.2.3. Technological landscape

Chapter 4. U.S. Breast Prosthetic Market: Product Type Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. U.S. Breast Prosthetic Market Movement Analysis
• 4.3. U.S. Breast Prosthetic Market Size & Trend Analysis, by Product Type, 2021 - 2033 (USD Million)
• 4.4. Full Breast Prosthesis
  • 4.4.1. Full Breast Prosthesis Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.5. Partial Breast Prosthesis (Shapers/Shells)
  • 4.5.1. Partial Breast Prosthesis (Shapers/Shells) Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.6. Specialty/Functional Prosthesis
  • 4.6.1. Specialty/Functional Prosthesis Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. U.S. Breast Prosthetic Market: Material Type Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. U.S. Breast Prosthetic Market Movement Analysis
• 5.3. U.S. Breast Prosthetic Market Size & Trend Analysis, by Material Type, 2021 to 2033 (USD Million)
• 5.4. Silicone Breast Forms
  • 5.4.1. Silicone Breast Forms Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.4.2. Standard Silicone
    • 5.4.2.1. Standard Silicone Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.4.3. Lightweight
    • 5.4.3.1. Lightweight Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.5. Foam and Fabric Breast Forms/Non-silicone
  • 5.5.1. Foam and Fabric Breast Forms/Non-silicone Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.6. Others (Custom Polymer Blends, 3D Printed)
  • 5.6.1. Others (Custom Polymer Blends, 3D Printed) Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. U.S. Breast Prosthetic Market: Application/Indication Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. U.S. Breast Prosthetic Market Movement Analysis
• 6.3. U.S. Breast Prosthetic Market Size & Trend Analysis, by Application/Indication, 2021 to 2033 (USD Million)
• 6.4. Post-Mastectomy Care
  • 6.4.1. Post-Mastectomy Care Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.5. Lumpectomy/Partial Mastectomy
  • 6.5.1. Lumpectomy/Partial Mastectomy Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.6. Breast Augmentation (Non-Surgical)
  • 6.6.1. Breast Augmentation (Non-Surgical) Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.7. Congenital Asymmetry
  • 6.7.1. Congenital Asymmetry Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.8. Others
  • 6.8.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. U.S. Breast Prosthetic Market: Distribution Channel Estimates & Trend Analysis

• 7.1. Segment Dashboard
• 7.2. U.S. Breast Prosthetic Market Movement Analysis
• 7.3. U.S. Breast Prosthetic Market Size & Trend Analysis, by Distribution Channel, 2021 to 2033 (USD Million)
• 7.4. Online Retailers/E-commerce Platforms
  • 7.4.1. Online Retailers/E-commerce Platforms Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 7.5. Retail Pharmacies & Medical Supply Stores
  • 7.5.1. Retail Pharmacies & Medical Supply Stores Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 7.6. Specialty Stores & Lingerie Boutiques
  • 7.6.1. Specialty Stores & Lingerie Boutiques Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 7.7. Direct Sales (Manufacturer to Provider/Consumer)
  • 7.7.1. Direct Sales (Manufacturer to Provider/Consumer) Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 7.8. Hospital & Clinic Sales (Procurement)
  • 7.8.1. Hospital & Clinic Sales (Procurement) Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Market Participant Categorization
• 8.2. Key Company Profiles
• 8.3. Company Share Analysis, 2024
  • 8.3.1. Tiger Aesthetics Medical, LLC
    • 8.3.1.1. Company Overview
    • 8.3.1.2. Financial Performance
    • 8.3.1.3. Product Benchmarking
    • 8.3.1.4. Strategic Initiatives
  • 8.3.2. Anita international Corporation
    • 8.3.2.1. Company Overview
    • 8.3.2.2. Financial Performance
    • 8.3.2.3. Product Benchmarking
    • 8.3.2.4. Strategic Initiatives
  • 8.3.3. Nearly Me
    • 8.3.3.1. Company Overview
    • 8.3.3.2. Financial Performance
    • 8.3.3.3. Product Benchmarking
    • 8.3.3.4. Strategic Initiatives
  • 8.3.4. Allergan (AbbVie)
    • 8.3.4.1. Company Overview
    • 8.3.4.2. Financial Performance
    • 8.3.4.3. Product Benchmarking
    • 8.3.4.4. Strategic Initiatives
  • 8.3.5. Mentor Worldwide LLC (Johnson & Johnson)
    • 8.3.5.1. Company Overview
    • 8.3.5.2. Financial Performance
    • 8.3.5.3. Product Benchmarking
    • 8.3.5.4. Strategic Initiatives
  • 8.3.6. Amoena Medizin-Orthopadie-Technik GmbH
    • 8.3.6.1. Company Overview
    • 8.3.6.2. Financial Performance
    • 8.3.6.3. Product Benchmarking
    • 8.3.6.4. Strategic Initiatives
  • 8.3.7. American Breast Care
    • 8.3.7.1. Company Overview
    • 8.3.7.2. Financial Performance
    • 8.3.7.3. Product Benchmarking
    • 8.3.7.4. Strategic Initiatives
  • 8.3.8. Elkem
    • 8.3.8.1. Company Overview
    • 8.3.8.2. Financial Performance
    • 8.3.8.3. Product Benchmarking
    • 8.3.8.4. Strategic Initiatives
  • 8.3.9. Trulife
    • 8.3.9.1. Company Overview
    • 8.3.9.2. Financial Performance
    • 8.3.9.3. Product Benchmarking
    • 8.3.9.4. Strategic Initiatives